The mission of the JAX Cancer Center is to discover precise genomic solutions for cancer by making basic discoveries with human impact. Committed to our role as an NCI-designated basic research Cancer Center, we harness our transdisciplinary strengths in complex genetics and functional genomics to achieve this goal.
An NCI-designated Cancer Center since 1983
The JAX Cancer Center (JAXCC) is a National Cancer Institute-designated Cancer Center complemented by institutional education, resource and service initiatives that support cancer research worldwide. A major barrier to improving cancer treatment is the genetic complexity of cancer and the genetic diversity of cancer patients. The multitude of mutations found in each cancer type limits the development of a common therapeutic, and cancer’s genetic diversity and instability leads to resistance to therapies. Moreover, genetic diversity among patients contributes to varied responses to any single treatment. At the JAXCC, we are developing strategies to convert this problem of genetic complexity into an advantage in therapeutic discovery.
JAXCC has scientific strengths in cancer genomics, genetics, cell biology, and advanced animal and computational models of human cancer, all of which are centered on developing approaches to precision medicine. Our focus on complex genetics and functional genomics, the scale of our model creation and experimentation, and the integration of our diverse talents make the JAXCC a unique enterprise.
31st Annual Short Course on Experimental Models of Human Cancer Flyer
The program purposefully provides a broad survey of the cancer research and experimental modeling from systems and computational genetics, to the tumor microenvironment and tumor progression, to inflammation and immunotherapy. Details here.
Cancer Arms Race
Leveraging the power of genomics to disarm cancer
The Spring edition of Search Magazine is dedicated to finding a cure for cancer.